CD274 and Merkel cell skin cancer: Immunotherapy with checkpoint inhibitors, such as anti‐PDL1/‐PD1, is the first‐line treatment for MCC but a large fraction of patients do not respond (Kaufman et al, 2016; Nghiem et al, 2016).